S&P 500 7,323.63 −0.23%
Nasdaq 24,429.89 +0.42%
S&P/TSX 34,578.05 −2.09%
Apple 352.45 +0.15%
Nvidia 150.96 −2.89%
Microsoft 508.29 +0.40%
Shopify 199.78 −1.50%
Royal Bank 272.26 −3.11%
CAD/USD 0.6991 −0.04%
PRE-MKT · 06:05 ET
Market ClerkRecap
Thu Nov 19 · pre-market7 signals on Nov 18520 insider buys this week · $248.1MCIRO short report next: Nov 30The week ahead
DV
INSIDER · VIR · Vir Biotechnology, Inc. · EVP, GENERAL COUNSEL, CORP SEC

de Verneuil Vanina

Every open-market transaction filed under this name, Nov 2 to Nov 3.

Filings
2
0 buys · 2 sells
Bought
—
open market, at cost
Sold
$42K
includes scheduled sales
Buys since
—
no current price on file

Filings

SEC FORM 4 · OPEN MARKET
TradedTickerCompanyRoleTypeSharesPriceValueSince
Nov 3VIRVir Biotechnology, Inc.EVP, General Counsel, Corp SecSell2,407$11.10$27K—
Nov 2VIRVir Biotechnology, Inc.EVP, General Counsel, Corp SecSell1,343$11.33$15K—

"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.